<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000405812"><TermName>SGN-30</TermName><TermDefinition><DefinitionText>A monoclonal antibody that binds to cells that have the CD30 antigen on their surface, including Hodgkin disease cells and cells from anaplastic large cell lymphoma, and cutaneous T-cell lymphoma. SGN-30 is being studied in the treatment of cancer. It is a type of monoclonal antibody.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><SpanishTermName>SGN-30</SpanishTermName><SpanishTermDefinition><DefinitionText>Anticuerpo monoclonal que se une a las células que tienen el antígeno CD30 en sus superficies, como las células de la enfermedad de Hodgkin y las células del linfoma anaplásico de células grandes, y del linfoma cutáneo de células T. El SGN-30 está en estudio para el tratamiento del cáncer. Es un tipo de anticuerpo monoclonal.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2004-11-05</DateFirstPublished><DateLastModified>2007-10-23</DateLastModified></GlossaryTerm>
